Are We Missing Vitamin Deficiencies in Parkinson\u27s Disease? by Hariharan, Praveen, et al.
Graduate Medical Education 
Research Journal 
Volume 2 Issue 1 Article 81 
September 2020 
Are We Missing Vitamin Deficiencies in Parkinson's Disease? 
Praveen Hariharan et al. 
Follow this and additional works at: https://digitalcommons.unmc.edu/gmerj 
 Part of the Higher Education Commons, and the Medicine and Health Sciences Commons 
Recommended Citation 
Hariharan, P. Are We Missing Vitamin Deficiencies in Parkinson's Disease?. Graduate Medical Education 
Research Journal. 2020 Sep 29; 2(1). 
https://digitalcommons.unmc.edu/gmerj/vol2/iss1/81 
This Conference Proceeding is brought to you for free and open access by DigitalCommons@UNMC. It has been 
accepted for inclusion in Graduate Medical Education Research Journal by an authorized editor of 
DigitalCommons@UNMC. For more information, please contact digitalcommons@unmc.edu. 
Are We Missing Vitamin Deficiencies in Parkinson's Disease? 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 
License. 
This conference proceeding is available in Graduate Medical Education Research Journal: 
https://digitalcommons.unmc.edu/gmerj/vol2/iss1/81 
Graduate Medical Education Research Journal64 Poster Presentations
*Names in bold type indicate presenting author.
Conclusion: CPM and QM set by ACC/AHA 
are not always met during care of post-AMI 
patients. One common barrier is documenting 
contraindications to recommended therapies. 
Quality improvement projects should be 
implemented to optimize the rate of CPM and 
QM met. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.058
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Background: The use of left ventricular 
assist devices (LVAD), both as bridge to 








last few years. The vast majority of these 
patients are eligible for electrical implantable 







of data on the impact of LVAD placement on 
the right ventricular lead integrity in these 
devices
Methods: We studied a total of 50 patients 
who had implantable cardioverter device 
(single, dual chamber and biventricular 
device) prior to LVAD placement at the 
University of Nebraska between 2017 
and 2019, a chart review was done to 
identify patients with right ventricular lead 
dysfunction that was diagnosed post LVAD 
implantation.
Results: The mean age of patients at the time 
of LVAD was 54 (+/-14) years, the study 
included 41 males (82%). Forty-two patients 
had Heartmate III, four had Heartmate II  
and four patients had Heartware LVAD. 
Twenty seven patients had single or dual 
chamber ICD (54%) while 23 patients had a 
biventricular ICD (46%). Right ventricular 
lead malfunction was reported in 18 patients 
(36%) within 6 months of LVAD implantation. 








different in the RV lead malfunction group 
compared to the rest of the patients.
Conclusion: There is a high incidence of right 
ventricular lead dysfunction post implantation 
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Background: Parkinson’s disease (PD) 
management focuses on quality of life, 
including adequate nutrition. Extensive 









commonly missed. Many new neurological 
symptoms are attributed to disease 
progression without ruling out these treatable 
conditions.
Methods: We present three cases of PD 
patients with diverse neurological symptoms 
whose workup showed reversible vitamin 

Results: Case 1 This 81-year-old male 
physician with PD developed weight 
loss, irritability, and dementia attributed 
to advanced disease. Workup revealed 
low thiamine (B1) of 30 nmol/L (70-180), 
pyridoxine (B6) of 5.2 nmol/L (20.0-125.0), 
cobalamin (B12) of 72 pg/mL (180-914), and 
25-hydroxyvitamin D of 14 ng/mL (30-80). 
He was noncompliant with replacement and 
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to PD. She was considered for discharge 
until a dietary history revealed that a typical 
meal was diet soda and white bread. Serum 
B1 (49 nmol/L), B6 (<5.0 nmol/L), and 
folate (5.4 ng/mL) were low. Confusion 
and hallucinations resolved three days 
after replacement. Case 3 This 46-year-old 
policeman with PD presented for a second 
opinion in the Comprehensive PD Clinic. 
He complained of trouble walking and 
forgetfulness thought related to his PD. B12 
was low (176 pg/mL) and normalized with 
replacement. Symptoms resolved within eight 
weeks.
Conclusion: Common symptoms of PD 
including gait problems, cognitive impairment, 









easily correctable. We are currently collecting 
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their impact on disease characteristics and 
common clinical assessments.
Methods: 118 patients from our PD clinic 
underwent serum testing for thiamine 
(B1), pyridoxine (B6), cobalamin (B12) 
and 25-hydroxy cholecalciferol (D3). We 
compared age, BMI, disease duration, United 
Parkinson’s Disease Rating Scale (UPDRS), 
Mini Mental Status Examination (MMSE), 
levodopa equivalent daily dose (LEDD), and 






included a nonparametric Wilcoxon two-
sample test and nonparametric Pearson and 
Spearman correlations.











more (B1 = 6, B6 = 26, B12 = 44, and D3 
= 24). Average UPDRS score was 35 with 








higher (712 mg) compared to the normal 



















years; p=0.093). Both groups had similar 
MMSE scores and report of falls. There were 
no linear correlations between vitamin levels 
and age, BMI, disease duration, UPDRS, 
MMSE, or LEDD.







present in 56% of our PD patients, there was 
not a strong correlation between serum levels 
and objective clinical measurements. Sample 
size limited statistical power and we will 
repeat analyses as more patients are enrolled. 
There are many other objective measures that 
can be included in future studies. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.080
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Background: Asthma exacerbation is a 
leading cause of emergency department 
visits and one of the top indications for 
hospitalization in children. Not only does this 
burden the medical care system with accruing 
costs and resources, these exacerbations are 
highly preventable given a strong medical 
home and a practical model of pediatric 
asthma care. Our aim was to perform a 
systemic review of literature to evaluate the 
existent models of pediatric asthma care with 
clinical and public health outcomes.
Methods: The Up to Date, Cochrane Library, 
and PubMed databases were queried using 
the search terms “Models of Pediatric Asthma 
Care”. We included all original, full-text 
abstracts published after 2010. We excluded 
abstracts pertaining to novel agents in 
treatment, ED/inpatient management, school-
based protocols, complementary/alternative 
medication, environmental and epigenetic 
factors.
Results: The proposed models in literature 
are as follows: 
1. Subgroup Analyses from the Prompting 
Asthma Intervention in Rochester-
Uniting Parents and Providers Trial 
(Goldstein et all, 2018).
2. Children’s Hospital Boston Community 
Asthma Initiative (Sommer et all, 2011).
3. Medical Home Model (Rojanasarot et 
all, 2018).
4. Ensemble Learning Model (Khasha R et 
all, 2019).
5. Practice Organization Model (Ruffner 
MA et all, 2018).
Conclusion: Asthma continues to be a major 
public health problem despite novel treatment 
agents and guideline-based management. 
An ideal theoretical model would include 
a) family educational programs/community 
resources, b) severity/control assessment,  
d)ensuring access of medication/ insurance 
coverage, e) addressing environmental  
triggers, f)frequent follow up care for 
susceptible children, g) addressing co-morbid 
conditions, and h) implementing legislative 
policy change. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.082
